About the Authors

Johanna Nattenmüller

Johanna.nattenmueller@med.uni-heidelberg.de

Affiliations Department of Diagnostic and Interventional Radiology, University Hospital, Im Neuenheimer Feld, Heidelberg, Germany, Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Im Neuenheimer Feld, Heidelberg, Germany, Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at University of Heidelberg, Amalienstraße, Heidelberg, Germany

Raoul Wochner

Affiliations Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Im Neuenheimer Feld, Heidelberg, Germany, Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at University of Heidelberg, Amalienstraße, Heidelberg, Germany

Thomas Muley

Affiliations Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Im Neuenheimer Feld, Heidelberg, Germany, Translational Research Unit (STF), Thoraxklinik at University of Heidelberg, Amalienstraße, Heidelberg, Germany

Martin Steins

Affiliations Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Im Neuenheimer Feld, Heidelberg, Germany, Department of Thoracic Oncology, Thoraxklinik at University of Heidelberg, Amalienstraße, Heidelberg, Germany

Simone Hummler

Affiliations Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Im Neuenheimer Feld, Heidelberg, Germany, Department of Thoracic Oncology, Thoraxklinik at University of Heidelberg, Amalienstraße, Heidelberg, Germany, Department of Pneumology and Respiratory Critical Care Medicine, Thoraxklinik at University of Heidelberg, Amalienstraße, Heidelberg, German

Birgit Teucher

Affiliation Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Im Neuenheimer Feld, Heidelberg, Germany

Joachim Wiskemann

Affiliation Division of Medical Oncology, National Center for Tumor Diseases (NCT); Heidelberg University Hospital, Im Neuenheimer Feld, Heidelberg, Germany

Hans-Ulrich Kauczor

Affiliations Department of Diagnostic and Interventional Radiology, University Hospital, Im Neuenheimer Feld, Heidelberg, Germany, Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Im Neuenheimer Feld, Heidelberg, Germany, Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at University of Heidelberg, Amalienstraße, Heidelberg, Germany

Mark Oliver Wielpütz

Affiliations Department of Diagnostic and Interventional Radiology, University Hospital, Im Neuenheimer Feld, Heidelberg, Germany, Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Im Neuenheimer Feld, Heidelberg, Germany, Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at University of Heidelberg, Amalienstraße, Heidelberg, Germany

Claus Peter Heussel

Affiliations Department of Diagnostic and Interventional Radiology, University Hospital, Im Neuenheimer Feld, Heidelberg, Germany, Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Im Neuenheimer Feld, Heidelberg, Germany, Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at University of Heidelberg, Amalienstraße, Heidelberg, Germany

Competing Interests

Patent Method and Device For Representing the Microstructure of the Lungs. IPC8 Class: AA61B5055FI, PAN: 20080208038, Inventors: W Schreiber, U Wolf, AW Scholz, CP Heussel. Consultation or other fees: Schering-Plough 2009, 2010; Pfizer 2008-2014; Basilea 2008, 2009, 2010; Boehringer Ingelheim 2010-2016; Novartis 2010, 2012, 2014; Roche 2010; Astellas 2011, 2012, 2015; Gilead 2011-2015; MSD 2011-2013; Lilly 2011; Intermune 2013-2014; Fresenius 2013, 2014; Olympus 2015. Research funding: Siemens 2012-2014; Pfizer 2012-2014; MeVis 2012, 2013; Boehringer Ingelheim 2015, 2016. Expert testimony: No. Tobacco Industry: No relation. Lecture fees: Gilead 2008-2014; Essex 2008, 2009, 2010; Schering-Plough 2008, 2009, 2010; AstraZeneca 2008-2012; Lilly 2008, 2009, 2012; Roche 2008, 2009; MSD 2009-2014; Pfizer 2010-2014; Bracco 2010, 2011; MEDA Pharma 2011; Intermune 2011-2014; Chiesi 2012; Siemens 2012; Covidien 2012; Pierre Fabre 2012; Boehringer Ingelheim 2012, 2013; Grifols 2012; Novartis 2013-2016; Basilea 2015, 2016; Bayer 2016. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceptualization: JN CPH MOW SH SM HUK. Data curation: RW TM JN. Formal analysis: TM RW. Investigation: RW JN. Methodology: JN CPH RW. Project administration: CPH MOW HUK MS. Resources: CPH SH MS HUK JW. Software: JN RW TM CPH. Supervision: CPH MOW HUK. Validation: MS SH HUK JW. Visualization: JN RW. Writing – original draft: JN. Writing – review & editing: JN RW MS SH HUK JW MOW CPH BT.